![](https://gritdaily.com/wp-content/uploads/2022/02/avatar_user_546_1644877940-151x151.jpg)
Paul Brennan is a Grit DAily contributor and president/CEO of NervGen Pharma Corp., a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. He can be reached at pb[email protected]
More articles by Paul Brennan
![](https://gritdaily.com/wp-content/uploads/2021/01/iStock-1199813214-1-300x169.jpg)
Paul Brennan
on January 7, 2021
The Acceleration of Alzheimer’s Disease Drug Innovations
![](https://gritdaily.com/wp-content/uploads/2020/09/iStock-1050311928-1-300x169.jpg)
Paul Brennan
on December 23, 2020
Therapeutics Innovation in the Era of a Pandemic
![](https://gritdaily.com/wp-content/uploads/2020/11/iStock-905516158-300x200.jpg)
Paul Brennan
on November 17, 2020